BridgeMD
Compares treatment options for Gastric Cancer
Official title Stapler Reinforcement Patches Compared to Standard Staplers in Gastrojejunostomy
ClinicalTrials.gov ID: NCT06464978
What this study is testing
- What it's testing
- This is a multi-center, prospective, randomized controlled study aimed at compareing the impact of stapler reinforcement patches versus standard staplers on postoperative complications in gastrojejunostomy.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 85
You may be able to join if
- Age between 18 and 85 years.
- Pathologically diagnosed with gastric cancer and suitable for distal gastrectomy or subtotal gastrectomy.
- ECOG performance status of 0 or 1.
- ASA (American Society of Anesthesiologists) classification of I-III.
- Voluntary signed informed consent from the participant or their legal representative.
You likely can't join if
- Evidence of potential distant metastasis found preoperatively.
- History of other malignancies diagnosed within the past 5 years, or any malignancy treated with chemotherapy or radiotherapy.
- Significant contraindications for surgery (e.g., severe liver or kidney dysfunction).
- Participation in any other clinical trial within the last 6 months.
- Participants or their legal representatives unwilling to sign the informed consent or comply with the study protocol.
The study team makes the final eligibility decision.
Where it's taking place
- Nanchong, Sichuan, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Nanchong, Sichuan, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.